Metraipolis › archive › dc_7b99bb8ec159

The Age Factor in Ixekizumab Survival: Older Patients Show Higher Long-Term Treatment Survival — Europe PMC PMID:41155814

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155814
DOI
10.3390/medicina61101827
License (as archived)
solo-consultazione
Archived
2026-11-09T09:42:36.276Z
SHA-256 of the archived text
dace251e30c38f69ccb8d83e50eeeaae7246a1144442e316a7a232b381b63474
Stable URL of this page
https://metraipolis.com/documento/dc_7b99bb8ec159

How to cite

The Age Factor in Ixekizumab Survival: Older Patients Show Higher Long-Term Treatment Survival — Europe PMC PMID:41155814 — Europe PMC (en), https://europepmc.org/article/MED/41155814 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b99bb8ec159 (Metraipolis archive dc_7b99bb8ec159, sha256 dace251e30c38f69ccb8d83e50eeeaae7246a1144442e316a7a232b381b63474)
BibTeX
@misc{dc7b99bb8ec159,
  title = {The Age Factor in Ixekizumab Survival: Older Patients Show Higher Long-Term Treatment Survival — Europe PMC PMID:41155814},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155814},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b99bb8ec159; sha256 dace251e30c38f69ccb8d83e50eeeaae7246a1144442e316a7a232b381b63474},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155814. Agents can read the archived copy with the MCP tool read_document.